Colon Cancer
Download
Report
Transcript Colon Cancer
Colon Neoplasia
VALERIE P. BAUER, MD
DIVISION OF COLON AND RECTAL SURGERY
ASSISTANT PROFESSOR
DEPARTMENT OF SURGERY
UTMB GALVESTON
JUNE 8, 2011
Epidemiology
COMMON
INCREASING INCIDENCE
DECREASING MORTALITY
Epidemiology
Third most common diagnosed cancer and cause of
cancer death annually
1 million people develop CRC annually
150,000 cases will be diagnosed in US
Probability of individual developing CRC in US is %6
over a lifetime
Population risk factors
Age
Ethnicity
Race
Socioeconomic status
Etiology
AGE
DIETARY
ENVIRONMENTAL
PREDISPOSING MEDICAL CONDITIONS:
PRIOR HISTORY COLON CANCER OR POLYPS
INFLAMMATORY
GENETIC
Dietary Risk Factors for CRC
Saturated animal fat
Red meat
High in iron- a pro-oxidant
May increase free radicals that damage mucosa
Charbroiled meat contains aromatic hydrocarbons
Increasing RM consumption by 3.5 oz/ day is associated with 1217% increased risk of CRC
Fruit and vegetables
Contain anti-oxidants
Studies show no association between high fruit and vegetable
consumption and risk reduction for CRC
Dietary Risk Factors for CRC
Fiber
Conflicting data
Increases intestinal transit, decreases exposure to carcinogens
May dilute or absorb carcinogens
Beneficial effect on colon- not rectum
Prostate, Lung, Colorectal, and Ovarian Screening Trial
European Prospective Investigation into Cancer and Nutrition
Calcium
Binds and precipitates bile salts
Beneficial in two randomized double blind placebo controlled trials
1200mg/ day for 4 years
2000mg/ day 3 years
Dietary Risk Factors for CRC
Folate (Vitamin B)
Normal DNA methylation
Folate deficiency may disrupt DNA synthesis repair or loss of
control of proto-oncogene activity
High intake reduces the risk of CRC
1998 FDA required folate supplementation of flour, cereals,
and grain products
Alcohol
Increased risk for consumption o f 2 or more drinks a day
Environmental
Smoking
Two to three fold increase of adenoma risk in smokers
Defined significant risk as smoking greater than 20 cigarettes
for 35-40 years
Mechanism
Generates replication errors
DNA mismatch repair genes
Predisposing Medical Conditions
Inflammatory Bowel Disease
Ulcerative Colitis
2% risk at 10 years/ 8% at 20 years/ 18% at 30 years
Crohn’s Disease
Cholecystectomy
Bile salt irritation
Increased risk for proximal small bowel and colon malignancy
Ureterosigmoidostomy
Ureterosigmoid anastomosis at risk
26 year latency period
About 25% will develop neoplasia
Radiation
Acromegaly
Genetic
Hereditary Syndromes
Familial Adenomatous Polyposis
Hereditary Non-Polyposis Colorectal Cancer
Others
Peutz Jehger’s Syndrome
Family History
First degree relative with CRC or adenoma
Molecular Basis of CRC
ALTERATIONS IN REGULATORY MECHANISM
MUTATIONS
TRANSFORMATION
Alterations in Regulatory Mechanisms
Six basic changes
1. Self sufficiency in growth signals
2. Insensitivity to anti-growth signals
3. Evading apoptosis
4. Limitless potential for cell replication
5. Sustained angiogenesis
6. Development of ability to invade and metastasize
Genetic Mutations
Oncogenes
K-ras
most frequently mutated gene in CRC
Involved in transduction of exogenous growth signals
Tumor suppressor genes
Inhibit cellular proliferation or promote apoptosis
Both alleles must be inactivated: Two Hit Theory
APC gene mutation
Adenoma to cancer pathway
Found in 75% of sporadic cases of CRC
Causes hyperproliferation
Adenoma to Carcinoma Sequence
Normal
epithelium
Hyperproliferative
epithelium
APC
mutation
K-ras
mutation
Adenoma
DCC
Carcinoma
P53
mutations
Colon Cancer Screening
AVERAGE RISK
PERSONAL HISTORY OF ADENOMA OR CRC
FAMILY HISTORY OF ADENOMA OR CRC
HNPCC
FAP
IBD
Average Risk
Who is average risk?
No family or personal history of CRC
No symptoms to suggest CRC
No unexplained anemia
No IBD
Recommendations: Begin at age 50
FOBT annually
Flex sig every 5 years
FOBT and flex sig every 5 years
Air contrast BE every 5-10 years
15-25% with negative results harbor neoplasia in proximal colon
Detects 50-80% stage I and II adenocarcinoma
Colonoscopy every 10 years
GOLD STANDARD
High Risk: Personal History Adenoma or CRC
Surveillance Colonoscopy is Test of Choice*
Prior adenoma
> 3 adenomas or > 1 large adenoma or high risk lesion calls for
repeat within 6 to 12 months
1-2 small adenomas- repeat in 3-5 years
Prior CRC
Post resection colonoscopy 1 year after surgery and every year
thereafter until colon is cleared
Followed by colonoscopy every 3-5 years thereafter
Family History Adenoma or CRC
For patients with first degree relatives diagnosed
with CRC:
Screening colonoscopy at age 40, or 10 years before
the age of diagnosis of the affected relative
HNPCC
Autosomal dominant inherited disorder
Mutation in MMR genes (genes that code for proteins
responsible for correcting errors during DNA replication)
Patients develop CRC between age 40 to 50
Most tumors are proximal to splenic flexure
Extra-colonic tumors are common
Amsterdam Criteria
3 family members affected by CRC or HNPCC extra-colonic cancer
2 generations with one member being a first degree relative of the
other
1 having cancer diagnosis before age 50
HNPCC
Screening colonoscopy
Begins at age 20-25
Repeat every 1-3 years
FAP
Autosomal dominant
Hundred and thousands of polyps
Cancer before age 40
Colonoscopy
Puberty
Repeat every 1-2 years
Increased risk for neoplasia 7-8
IBD
years after diagnosis for pancolitis and 12-15 years after dx left
colitis
Screening colonoscopy
7-8 years after initial diagnosis and
every 1-2 years thereafter with multiple
biopsies to detect dysplasia
12-15 years for left sided colitis and
ever 1-2 years thereafter
Colonoscopy
Barium Enema
Pedunculated Polyp
VA study
Flat Nonpolypoid Polyp
Prevalence 9%
Smaller more aggressive polyp
Formerly a eastern polyp
Best seen after training
High definition
Narrow band imaging
Chromoendoscopy
Colon Cancer Evaluation and
Staging
CLINICAL PRESENTATION
STAGING AND PROGNOSTIC FACTORS
HISTOLOGIC FACTORS
SPREADING PATTERNS
Clinical Presentation
Symptomatic patients
Abdominal pain= MC
Vague and non-specific
Poorly localized
Changes in bowel habits
Depends on the side of the lesion
Possibilities
Pencil thin stool
Mucus in BM
Rectal bleeding
17.5% patients had colorectal neoplasm in one series 570 patients
50 years or younger undergoing colonoscopy for bleeding
Occult blood in the stool
Preoperative Preparation
Evaluate operative risks
Nutrition
Co-morbidities (CAD, COPD, DM, Steroids)
Localize and confirm tumor
Review colonoscopy
Pathology
Radiography
Stage
CT CAP w/ oral and iv contrast
CEA
Bowel Prep
Controversial
No one likes operating in stool
Staging
Outdated
Dukes
A- Cancer limited to bowel wall
B- Cancer extends to extracolonic tissue
C- Cancer with regional lymph node metastasis
Current Staging System
TNM
Staging: TNM
• Tumor
T1- Into submucosa
T2- Into muscularis propria
T3- Through bowel wall
T4- Adjacent structures
Nodes
o N1- 1-3 nodes positive
o N2- 4 or more positive
Metastasis
M0- no metastasis
M1- Metastasis
Stage I
Any T1 or T2, N0, M0
Stage II
Any T3 or T4, N0, M0
Stage III
A- T1 or 2, N1, M0
B- T3 or 4, N1, M0
C- Any T, N2, M0
Stage IV
Histologic Factors
Histologic Grade
Well/ moderately/ poorly differentiated
Mucin Production
Signet-cell
Low curative resection rate
Mean survival 16 months
Venous Invasion
Perineural Invasion
Lymph Node Involvement
Most important prognostic indicator
Need 13 or more for accurate staging
CEA
Correlates with metastatic disease
> 15 mg/ml predicts increased risk of metastasis in otherwise curable
colon cancer
Spreading Patterns
Spreading Patterns
Intramural Spread
Rarely spreads this way
Extent of average spread is 2cm
Basis behind 5 cm margin
Transmural Spread
En-block resection indicated for
cure
Margins
5cm proximal and distal margin
High ligation of primary feeding
vessel
Radial Margins
Becomes an issue in rectal cancer
Pelvic Structures
Spreading Patters
Lymphatic
MC mechanism for metastatic disease
Causes metastatic liver disease
T1- 9% risk of positive LN
T2- 25% risk
T3- 45% risk
Hematogenous
Bypass liver and goes to systemic circulation
Explains lung mets in colon cancer
Synchronous
6% or less will have synchronous CRC
Think HNPCC
Give TAC
Distant
Liver
Lung
Surgical Management
PREOPERATIVE PREPARATION
REVIEW OF SURGICAL OPTIONS
Surgical Options
Right Colectomy
Lesion located in cecum/ ascending colon
Extended Right Colectomy
Lesion located in the transverse colon (hepatic flexure to splenic flexure
Left Colectomy
Lesion in descending colon
Sigmoid Colectomy
Total Abdominal Colectomy Ileorectal Anastomosis versus
Total Proctocolectomy Ileal Pouch Anal Anastomosis
HNPCC
Attenuated FAP/ FAP
Metachronous colon cancers
Distal obstruction with unknown proximal status